A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink
Opioid agonists, mixed agonist-antagonists and partial agonists | Osmosis
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Selective kappa opioid antagonists for treatment of addiction, are we there yet? - ScienceDirect
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Opioid receptors: drivers to addiction? | Nature Reviews Neuroscience
Deciphering the molecular basis of the kappa opioid receptor selectivity: A Molecular Dynamics study - ScienceDirect
Selective kappa opioid antagonists for treatment of addiction, are we there yet? | Semantic Scholar
Kappa receptor (KOR) function in neurocircuits of addiction. This... | Download Scientific Diagram
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Role of kappa-opioid receptors in stress and anxiety-related behavior. - Abstract - Europe PMC
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
A Practical Approach for the Management of the Mixed Opioid Agonist- Antagonist Buprenorphine During Acute Pain and Surgery - Mayo Clinic Proceedings
κ-opioid receptor - Wikipedia
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
Selective kappa opioid antagonists for treatment of addiction, are we there yet? | Semantic Scholar
Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction - ScienceDirect
Frontiers | Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors
Selective kappa opioid antagonists for treatment of addiction, are we there yet? | Semantic Scholar
The main causes of narcotic addiction (e.g., morphine) and strategies... | Download Scientific Diagram
For Healthcare Professionals | The Brain and Dependence
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
